FBInvestor
Stocks / Aptevo Therapeutics Inc
Institutional Ownership

Aptevo Therapeutics Inc

CUSIP 03835L702COM SHS NEWAPVOQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon